FindTrial
Sign In

Cathodal transcranial direct current stimulation

DEVICE8 trials

Sponsors

Federal University of Paraíba, Sheffield Hallam University, University of Calgary, University Hospital Tuebingen, University of Campinas, Brazil

Conditions

Cognitive ChangeDiabetes Type 2Epilepsy IntractableHemiplegic Cerebral PalsyInsulin ResistanceMigraineNervous System DiseasesObesity

Phase 2

Transcranial Direct Current Stimulation on the Risk of Falls and Lower Limb Function for Acute Stroke
CompletedNCT02422173
Federal University of ParaíbaStroke
Start: 2015-01-31End: 2015-04-30Updated: 2015-04-21
Stimulation for Perinatal Stroke Optimizing Recovery Trajectories
CompletedNCT03216837
University of CalgaryHemiplegic Cerebral Palsy, Perinatal Stroke
Start: 2017-07-21End: 2023-03-18Updated: 2024-03-28
The impact of transcranial direct current stimulation on drug-resistant temporal lobe epilepsy
Active, not recruitingPACTR202404691765975
Self fundedNervous System Diseases
Start: 2020-10-01Target: 30Updated: 2026-01-27

Unknown Phase

Dopamine Dorsolateral Prefrontal Cortex Behavioural Flexibility
CompletedNCT03068884
Sheffield Hallam UniversityCognitive Change
Start: 2017-03-01End: 2018-01-31Updated: 2018-02-22
Improving Insulin Sensitivity by Non-invasive Brain Stimulation in Persons With Insulin Resistance
NCT04052399
University Hospital TuebingenInsulin Resistance, Transcranial Direct Current Stimulation
Start: 2019-11-04End: 2021-12-31Target: 20Updated: 2020-05-14
Effects of Transcranial Direct Current Stimulation (tDCS) for the Treatment of Refractory Epilepsy
NCT04325360
University of Campinas, BrazilEpilepsy Intractable
Start: 2020-03-20End: 2022-12-20Target: 30Updated: 2020-03-27
Transcranial Direct Current Stimulation Plus Monoclonal Antibodies Acting on the CGRP Pathway for Migraine
CompletedNCT05161871
University of L'AquilaMigraine
Start: 2022-05-16End: 2023-04-16Updated: 2024-12-05
Enhancing Brain Health by TDCS in Persons with Overweight and Obesity
Active, not recruitingNCT05228067
University Hospital TuebingenDiabetes Type 2, Insulin Resistance, Obesity
Start: 2021-11-08End: 2025-12-31Target: 40Updated: 2025-03-30

Related Papers

Effectiveness of transcranial direct current stimulation and monoclonal antibodies acting on the CGRP as a combined treatment for migraine (TACTIC): Results of a randomized controlled trial
Cephalalgia2025-05-012 citations
Neuromodulation for Children With Hemiparesis and Perinatal Stroke
JAMA Neurology2025-02-0310 citations
Effectiveness of Transcranial Direct Current Stimulation and Monoclonal Antibodies Acting on the CGRP as a Combined Treatment for Migraine (TACTIC): Protocol for a Randomized, Double-Blind, Sham-Controlled Trial
Frontiers in Neurology2022-05-105 citations
Protocol for a cost–utility analysis of neurostimulation and intensive camp-based therapy for children with perinatal stroke and hemiparesis based on a multicentre clinical trial
BMJ Open2021-01-014 citations